Skip to content
MedsAcross

Medicine

Acetaminophen, Butalbital, Caffeine and Codeine 300 mg/50 mg/40 mg/30 mg capsule

Available on requestPrescription onlyUS FDAControlled, schedule CIIIGeneric name

Acetaminophen, Butalbital, Caffeine and Codeine 300 mg/50 mg/40 mg/30 mg capsule is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store and Dispense Store at 20° to 25°C (68° to 77°F). Store Butalbital…

Key facts

Active ingredient (INN)
Acetaminophen, Butalbital, Caffeine and Codeine
Brand
Sold under the generic name
Strength
300 mg/50 mg/40 mg/30 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules
Manufacturers
Actavis PharmaHikma Pharmaceuticals
Origin register
US FDA, United States
Storage
Store and Dispense Store at 20° to 25°C (68° to 77°F). Store Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules securely and dispose of properly.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CIII
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 July 2013
Identifiers
RxCUI 1431286, 993943DailyMed set ID 52321fe5-c001-4e2d-8149-3197ddc13764, 6e0e8abc-512b-42f7-8323-434c589edecfNDC 0591-2641, 0054-0650Application ANDA076560, ANDA215138

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule in 1 bottle, plastic0591-2641-01Actavis Pharma29 July 2013
100 capsule in 1 bottle0054-0650-25Hikma Pharmaceuticals9 May 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 July 1992Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Acetaminophen, Butalbital, Caffeine and Codeine

Clinical summary

Acetaminophen, Butalbital, Caffeine and Codeine is a fixed-dose combination of a barbiturate, a central nervous system stimulant and a methylxanthine. It is available as capsules for oral use. MedsAcross supplies Acetaminophen, Butalbital, Caffeine and Codeine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Acetaminophen, Butalbital, Caffeine and Codeine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Acetaminophen, Butalbital, Caffeine and Codeine 300 mg/50 mg/40 mg/30 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.